Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Shandong Weigao Medical Polymer Co. (SHWGF) had Revenue of $1.82B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$1.82B
Net Income	$315.02M
Cost of Goods Sold	$905.05M
Gross Profit	$915.37M
Operating Expenses	$1.44B
Operating Income	$380.77M
Non-Operating Income/Expense	$-25.54M
Pre-Tax Income	$355.23M
Normalized Pre-Tax Income	$346.05M
Income after Taxes	$300.83M
Income from Continuous Operations	$300.83M
Consolidated Net Income/Loss	$300.83M
Normalized Income after Taxes	$290.26M
EBIT	$380.77M
EBITDA	$515.94M
Weighted-Average Shares Outstanding (Basic)	4.55B
Weighted-Average Shares Outstanding (Diluted)	4.55B
Earnings per Share (EPS) (Basic)	$0.06
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$2.70B
Property, Plant, and Equipment	$908.79M
Long-Term Assets	$2.13B
Total Assets	$4.84B
Current Liabilities	$845.80M
Long-Term Debt	$389.52M
Long-Term Liabilities	$464.29M
Total Liabilities	$1.31B
Common Equity	$3.53B
Tangible Shareholders Equity	$2.81B
Shareholders Equity	$3.53B
Common Shares Outstanding	4.57B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$388.08M
Cash Flow from Investing Activities	$-153.62M
Cash Flow from Financial Activities	$-222.00M
Beginning Cash	$667.33M
End Cash	$687.55M
Increase/Decrease in Cash	$20.23M
Stock-Based Compensation	$5.01M
Common Stock Dividends Paid	$-121.10M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.10
Debt to Equity Ratio	0.16
Gross Margin	50.28%
Operating Margin	20.92%
EBIT Margin	20.92%
EBITDA Margin	28.34%
Pre-Tax Profit Margin	19.51%
Profit Margin	17.30%
Free Cash Flow	$305.27M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.38
Inventory Turnover	2.57
Receiveable Turnover	1.66
Days Sales in Receivables	219.85
Return on Equity	8.53%
Return on Tangible Equity	10.70%
Return on Assets	6.22%
Return on Investments	7.68%
Book Value Per Share	$0.77
Free Cash Flow per Share	$0.07
Operating Cash Flow per Share	$0.09

Data from Zacks Investment Research, Inc.